Overall rank by patents
#41,074
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 0 technology areas, active 2020–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search.
The verdict
JKM holds 6 US patents across 0 technology areas, rank #41,074 of 50,000 tracked assignees.
JKM Technologies, Llc has been granted 6 US utility patents between 2020 and 2023, placing JKM Technologies, Llc at rank #41,074 across all assignees tracked by PlainPatent. This portfolio spans 0 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.0 claims per patent. As a US Corporation, JKM Technologies, Llc is one of the more focused assignees in the PatentsView dataset. By volume, JKM sits between Jiangxi Tianyu Chemical Co., Ltd. (6 patents, rank #41,070) and Joben Bio-medical Co., Ltd. (6 patents, rank #41,078) - the closest US assignees by grant volume. The composite Innovation Score of 10.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2023, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. JKM Technologies, Llc's 1.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 0 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark JKM Technologies, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
JIANGXI TIANYU CHEMICAL CO., LTD.
6 patents
JIANGYIN BENGT I. SAMUELSSON INSTITUTE OF LIFE SCIENCE CO., LTD.
6 patents
JIANGZHONG PHARMACEUTICALS CO., LTD.
6 patents
JINGAO SOLAR CO., LTD.
6 patents
JLJ, Inc.
6 patents
JNTG CO., LTD.
6 patents
JOBDIVA, INC.
6 patents
JOBEN BIO-MEDICAL CO., LTD.
6 patents
JKM Technologies, LLC
6 patents
What this shows JKM holds 6 patents at rank #41,074, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #41,074 in granted patent volume.
JKM's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
11 Top 98% higher than 2% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 3 | 50.0% |
| 2021 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
| 2023 | 1 | 16.7% |
Overall rank by patents
#41,074
Across all tracked assignees
10.7 out of 100
How to use this portfolio
JKM's 6 grants land it in the top 98% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.